Drug Rhythm-Control Failure Widens Opening For Ablation, Say Cardiologists
This article was originally published in The Gray Sheet
Executive Summary
Drug-based rhythm-control therapy does not help keep patients with atrial fibrillation and heart failure alive any better than conventional heart failure drugs, researchers report in the June 19 New England Journal of Medicine